Mumbai: Pharma major Glenmark Pharmaceuticals, through its wholly owned subsidiary Glenmark Speciality SA, has received the approval of the Drugs Controller General of India (DCGI) to initiate patient enrollment for...
Mumbai: Glenmark Pharmaceuticals Ltd has announced the commercial launch of the world’s first fixed-dose nebulised therapy for the treatment of Chronic Obstructive Pulmonary Disease (COPD). The product, which combines the...
Mumbai: India’s fourth-largest pharma company Glenmark Pharmaceuticals’ shares are witnessing a massive rise after the company informed the bourses about its deal with US-based AbbVie for developing and commercialising its...
